Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Family Medicine | Gynecology | Infections | Internal Medicine | Nursing | Pathology | Pharmacy | Journal

Back to Journal Articles

Failure Rate of Cefixime for N. gonorrhoeae Infection Explored

Last Updated: January 08, 2013.

 

Increased risk of clinical treatment failure with minimum inhibitory concentration of ≥0.12 µg/mL

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
For Neisseria gonorrhoeae infections, the rate of clinical treatment failure with cefixime is 6.77 percent, and is associated with minimum inhibitory concentrations of 0.12 µg/mL or more, according to a study published in the Jan. 9 issue of the Journal of the American Medical Association.

TUESDAY, Jan. 8 (HealthDay News) -- For Neisseria gonorrhoeae (N. gonorrhoeae) infections, the rate of clinical treatment failure with cefixime is 6.77 percent, and is associated with minimum inhibitory concentrations (MICs) of 0.12 µg/mL or more, according to a study published in the Jan. 9 issue of the Journal of the American Medical Association.

Noting that increased MICs to cefixime have been associated with reports of clinical failure, Vanessa G. Allen, M.D., M.P.H., from Public Health Ontario in Toronto, and colleagues conducted a retrospective cohort study involving 291 N. gonorrhoeae culture-positive individuals at a single sexual health clinic to examine risk of cefixime-linked clinical treatment failure.

Of the 133 individuals (97 percent male) who returned for test of cure, the researchers found that 13 were culture positive and nine had experienced cefixime failure, involving urethral, pharyngeal, and rectal sites, for an overall clinical treatment failure rate of 6.77 percent. There was a 25 percent rate of clinical treatment failure with a cefixime MIC of 0.12 µg/mL or greater, compared with a 1.9 percent rate of infections with a cefixime MIC of less than 0.12 µg/mL (relative risk, 13.13).

"In summary, we identified a relatively high rate of clinical failure in a clinic in Toronto after treatment of N gonorrhoeae infections with cefixime, which was associated with elevated MICs," the authors write.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.


Previous: Methotrexate Offers Lasting Benefit in Juvenile Scleroderma Next: Single Embryo Transfer Policy Has Cut Multiple Pregnancy Rate

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.